What Has Been the Progress and Growth of the Fetal Bovine Serum Market in Recent Years?
The fetal bovine serum market has seen considerable growth due to a variety of factors.
• The market size of fetal bovine serum has seen substantial growth in the previous years. It will increase from $1.02 billion in 2024 to $1.07 billion in 2025, progressing at a compound annual growth rate (CAGR) of 5.6%.
Factors such as the expansion of the biopharmaceutical industry, the growth in cell-based therapies, and requirements for quality and consistency have contributed to this historic period growth.
What are the Market Size and Expected Growth Rates for the Fetal Bovine Serum Market?
The fetal bovine serum market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for fetal bovine serum is projected to experience substantial growth in the coming years, increasing to $1.34 billion by 2029 with a compound annual growth rate (CAGR) of 5.7%.
The expansion during the forecast period can be credited to the rising adaptation of cell therapies, the advent of advanced therapeutics, attention towards animal-free alternatives, and strategic partnerships between suppliers and customers. Key trends for the forecast period encompass a focus on quality and traceability, worldwide collaborations and partnerships, strategic mergers and acquisitions, tailored fetal bovine serum products, regulatory adherence, and ethical sourcing.
What Factors Are Driving Growth In The Fetal Bovine Serum Market?
The fetal bovine serum market is poised for growth, powered by an escalating demand for biopharmaceuticals in the forecasted time frame. Biopharmaceuticals, which are medicinal products sourced from animals, humans, and microorganisms through biotechnology, heavily depend on Fetal Bovine Serum (FBS). FBS is a popular substitute for animal cell culture media in the pharmaceutical industry, diagnostic laboratories, and among researchers for their cell culture needs in biologics research. In the year 2022, ProClinical Limited, a UK-based lifesciences service and consulting firm, registered an 11% YOY increase in their sales for pharmaceutical and vaccine segments, amounting to US$36.15mn. Hence, the burgeoning demand for biopharmaceuticals drives the expansion of the fetal bovine serum market.
How Is The Globa Fetal Bovine Serum Market Divided Into Key Segments?
The fetal bovine serum market covered in this report is segmented –
1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products
2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human And Animal Vaccine Production, Diagnostics, Other Applications
3) By End-User: Research And Academic Institutes, Biotechnology And Pharmaceutical Industry, Other End-Users
Subsegments:
1) By Charcoal Stripped: Standard Charcoal Stripped FBS, Heat-Inactivated Charcoal Stripped FBS
2) By Chromatographic: Ion Exchange Chromatography Purified FBS, Affinity Chromatography Purified FBS
3) By Dialyzed Fetal Bovine Serum: Standard Dialyzed FBS, Heat-Inactivated Dialyzed FBS
4) By Exosome Depleted: Standard Exosome Depleted FBS, Heat-Inactivated Exosome Depleted FBS
5) By Stem Cell: Stem Cell Grade FBS, Knockout Serum Replacement
6) By Other Products: Serum from Specific Animal Breeds, Custom-Processed FBS
Pre-Book The Fetal Bovine Serum Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Fetal Bovine Serum Market?
The surge in collaborative efforts between corporations and research institutions is emerging as a significant trend in the fetal bovine serum market. Prominent companies are banding together to enhance production abilities, broadening their market reach, and inventing new products. For example, GE Healthcare, a US-based company, joined forces with Oritain of New Zealand to create an independent test capable of validating the country of origin of fetal bovine serum (FBS). This is crucial for biomanufacturing firms since FBS sourced from different nations carries varying degrees of virus contamination risks.
Who Are the Key Players in the Fetal Bovine Serum Market?
Major companies operating in the fetal bovine serum market include:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Corning Incorporated
• Cytiva
• VWR International
• Sartorius AG
• Bio-Techne Corporation
• Atlas Biologicals Inc.
• R&D Systems Inc.
• Atlanta Biologicals Inc.
• Cyagen Biosciences
• GenClone Inc.
• Gemini Bio-Products
• Access Biologicals LLC
• Nucleus Biologics
• ZenBio Inc.
• Biowest
• Bovogen Biologicals Pty Ltd.
• TCS Biosciences Ltd.
• J R Scientific Inc.
• Rocky Mountain Biologicals Inc.
• Tissue Culture Biologicals
• Moregate Biotech
• Cell Applications Inc.
• Altogen Biosystems
• Axil Scientific Pte Ltd.
• Animal Technologies Inc.
• PAN- Biotech
• PAA Laboratories GmbH
• Peak Serum Inc.
What are the Regional Insights into the Fetal Bovine Serum Market?
North America was the largest region in the fetal bovine serum market in 2024. Asia-Pacific recorded the fastest growth during the forecast period. The regions covered in the fetal bovine serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
